GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
2

21st North ULGX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

21st North — daily ULGX Delayed
Market value
$2,182
Last close × shares
Volume
200
Shares, 2 Nov 2026

About 21st North

Its shares trade under the ticker ULGX. It has been listed since 30 May 1996. In the fiscal year to 30 June 2014, it reported revenue of $14.2m and a net loss of $7.6m. At that date it held total assets of $5.7m and shareholders' equity of −$7.0m.

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company is headquartered in Minneapolis, Minnesota. The firm offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm has no operations. The firm intends to dissolve.

Figures and description from our data supplier, not checked against the company's own report.

More about 21st North →

Latest on 21st North

Our reporting

We have not reported on 21st North yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is 21st North's ticker?

21st North trades as ULGX on its US listing, under ISIN US9172731047.

What was 21st North's last closing price?

0.00 on 2 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.